全球即时血糖监测市场规模、份额、趋势和成长分析报告（2026-2034）

预计到 2034 年，照护现场将从 2025 年的 40.9 亿美元成长至 65 亿美元，2026 年至 2034 年的复合年增长率为 5.26%。

全球照护现场血糖监测市场正经历显着成长，这主要得益于糖尿病盛行率的上升和快速诊断解决方案需求的增加。即时血糖照护现场设备能够实现即时血糖监测，从而支援及时的临床决策和有效的疾病管理。人们对自我管理和预防性医疗保健意识的提高，正在推动即时血糖监测设备在医院和居家照护中的应用。

携带式血糖仪、连续血糖监测系统和智慧型手机连接检测设备的科技进步是成长要素。远端医疗服务和远端患者监护的扩展进一步刺激了市场需求。政府推广糖尿病筛检和管理计画的措施也促进了市场成长。人口老化和久坐的生活方式加剧了全球糖尿病负担。

未来，人工智慧 (AI) 与云端资料管理系统的融合有望提升血糖监测仪的精准度和连接性。新兴经济体由于医疗服务覆盖范围的扩大和健康意识的增强，将带来巨大的成长机会。持续创新，致力于提升产品的便利性和可负担性，将有助于其长期普及应用。随着慢性病管理日益受到重视，市场预计将持续保持强劲成长动能。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球即时血糖监测市场：依产品类型划分

• 市场分析、洞察与预测
• 采血笔和条带
• 血糖仪

第五章 全球即时血糖监测市场：依应用领域划分

• 市场分析、洞察与预测
• 1型糖尿病
• 2型糖尿病

第六章 全球即时血糖监测市场：依最终用户划分

• 市场分析、洞察与预测
• 医院和诊所
• 居家医疗环境
• 其他的

第七章 全球即时血糖监测市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Prodigy Diabetes Care LLC
  • Ascensia Diabetes Care Holdings AG
  • ACON Laboratories Inc
  • EKF Diagnostics Holdings Plc
  • Trividia Health Inc
  • Platinum Equity Advisors LLC
  • Abbott Laboratories
  • Nipro
  • F. Hoffmann-La Roche Ltd
  • Nova Biomedical Corporation

The Point-of-Care Glucose Testing Market size is expected to reach USD 6.50 Billion in 2034 from USD 4.09 Billion (2025) growing at a CAGR of 5.26% during 2026-2034.

The Global Point-of-Care Glucose Testing Market is witnessing significant growth driven by the rising prevalence of diabetes and increasing demand for rapid diagnostic solutions. Point-of-care devices enable immediate glucose monitoring, supporting timely clinical decisions and effective disease management. Growing awareness about self-monitoring and preventive healthcare is encouraging adoption among both hospital settings and home-care users.

Key growth drivers include technological advancements in portable glucose meters, continuous glucose monitoring systems, and smartphone-integrated testing devices. The expansion of telehealth services and remote patient monitoring has further boosted demand. Government initiatives promoting diabetes screening and management programs are also strengthening market expansion. Increasing geriatric population and sedentary lifestyles are contributing to the growing burden of diabetes worldwide.

In the future, integration of artificial intelligence and cloud-based data management systems is expected to enhance accuracy and connectivity of glucose testing devices. Emerging economies will provide substantial growth opportunities due to expanding healthcare access and rising health awareness. Continuous innovation aimed at improving convenience and affordability will support long-term adoption. As chronic disease management becomes a priority, the market is set for sustained and dynamic growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Lancing Devices and Strips
• Blood-Glucose Meter

By Application

• Type-1 Diabetes
• Type-2 Diabetes

By End User

• Hospitals and Clinics
• Home Care Settings
• Others

COMPANIES PROFILED

• Prodigy Diabetes Care LLC, Ascensia Diabetes Care Holdings AG, ACON Laboratories Inc, EKF Diagnostics Holdings plc, Trividia Health Inc, Platinum Equity Advisors LLC, Abbott Laboratories, Nipro, F HoffmannLa Roche Ltd, Nova Biomedical Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Lancing Devices and Strips Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Blood-Glucose Meter Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Type-1 Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Type-2 Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL POINT-OF-CARE GLUCOSE TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Prodigy Diabetes Care LLC
  • 9.2.2 Ascensia Diabetes Care Holdings AG
  • 9.2.3 ACON Laboratories Inc
  • 9.2.4 EKF Diagnostics Holdings Plc
  • 9.2.5 Trividia Health Inc
  • 9.2.6 Platinum Equity Advisors LLC
  • 9.2.7 Abbott Laboratories
  • 9.2.8 Nipro
  • 9.2.9 F. Hoffmann-La Roche Ltd
  • 9.2.10 Nova Biomedical Corporation